Evaluation of efficacy of topical corticosteroid once daily plus emollient cream once daily vs. topical corticosteroid cream twice daily alone in chronique plaque psoriasis

Evaluation of efficacy of topical corticosteroid plus emollient cream vs. topical corticosteroid cream alone in chronique plaque psoriasis. A randomised paralell gropu study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON25273

Enrollment

Registered

2013-07-10

Start date

2013-08-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Plaque psoriasis

Interventions

Investigational compound : non-steroideal, anti-inflammatory moisturizing cream containing rhamnosoft, ceramides and L-isoleucine (ILE) (Nutratopic Pro AMP) Comparator: emollient cream containing gly

Eligibility

Inclusion criteria

Inclusion criteria: Men and women aged 18 years or more Plaque psoriasis mild to moderate

Exclusion criteria

Exclusion criteria: Severe plaque psoriasis

Design outcomes

Primary

Measure	Time frame
Facial modified Eczema Area Severity Index (EASI) using a 4-scale score (from 0 to 3) (absent, mild, moderate, severe) evaluating: erythema, infiltration, lichenification, erosion	—

Secondary

Measure	Time frame
Physician Global assessment (a 6-point scale) from 0 to 5; Tolerability will be evaluated at week 3 and at week 6 using a 4-point score (from 0: very good tolerability to 3: very poor tolerability)	—

Contacts

Public ContactMassimo Milani

Via Nota 18

masmilan2000@yahoo.it0039026431247

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)